Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Fresenius SE & Co Stock Quote

Fresenius SE & Co (OTC: FSNU.F)

$26.65
(-4.5%)
-$1.26
Price as of April 19, 2024, 10:40 a.m. ET

Fresenius SE & Co Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
FSNU.F -0.68% -44.91% -11.24% -85%
S&P +24.56% +72.51% +11.52% +289%

Fresenius SE & Co Company Info

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.